Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma
Latest Information Update: 05 Jul 2021
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary) ; Zanubrutinib (Primary)
- Indications CNS cancer; Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 05 Jul 2021 New trial record